U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07288320) titled 'An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania' on Dec. 15.
Brief Summary: The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving manic symptoms in adults with bipolar I disorder who are currently experiencing an episode of mania with or without mixed features.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Bipolar I Disorder
Mania
Intervention:
DRUG: NBI-1117568
Oral administration
DRUG: Placebo
Oral administration
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Neur...